ENTITY
J.B. Chemicals & Pharmaceuticals

J.B. Chemicals & Pharmaceuticals (JBCP IN)

37
Analysis
Health Care • India
J.B. Chemicals & Pharmaceuticals Ltd. manufactures pharmaceuticals, chemicals and agro-based products. The Group's products include metrogyl, rantac (a ranitidine-based formula), and nicardia, a cardiac care medicine. The Company has an agreement with Justesa Imagen, to manufacture and market diagnostics under the "Trazograf" brand name.
more
•03 Jan 2024 07:43•Broker

Axis Research Scorecard Report for Dec 2023

NEW YEAR PICKS 2024: New Year, New Horizons, which contains deeply-researched 9 stocks that are best-placed to deliver excellent performance in 2024.

Logo
678 Views
Share
•30 Sep 2023 00:05

Supports Starting to Break; Upgrading Non-U.S. Small-Caps to Overweight; Transports/Comm/HC Buys

Support levels on global indexes (EURO STOXX 50, $ACWX, $EFA) beginning to break as $DXY and 10-year Treasury yield $TNX break above $105.70 and...

Logo
698 Views
Share
•08 Apr 2022 11:39•Broker

Pharmaceutical Sector: Sequentially Flattish Quarter Expected

4QFY22 is expected to be a flattish quarter for most Pharma companies in our coverage universe. We expect a few companies to benefit from the US...

Logo
473 Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.2k Views
Share
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Logo
5.1k Views
Share
x